Iovance Biotherapeutics (0JDK.L) Stock Price
$3.59 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
2 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Iovance Biotherapeutics, AI stock picks, stock alerts and much more.
0JDK.L AI Stock Analysis
AI stock analysis for 0JDK.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Iovance Biotherapeutics (0JDK.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Iovance Biotherapeutics (0JDK.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Iovance Biotherapeutics (0JDK.L), currently trading at $3.59, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0JDK.L
-
Iovance Biotherapeutics, Inc.
-
Symbol
0JDK.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
1.2B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$492.2 0.4% |
5 |
 |
Neurocrine Biosciences 0K6R.L |
$106.7 2% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$5.65 10.4% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$5.25 4% |
5 |
 |
Walgreens Boots Alliance 0LSZ.L |
$11 0.1% |
4 |
News
0JDK.L Alternative Data
Web Traffic
Iovance Biotherapeutics receives an estimated 26475 monthly visitors to iovance.com.
-
Web Traffic
26475
-
Change from Previous Month
6%
-
3 Month Change
16.6%
-
YoY Change
16.6%
Twitter Followers
Iovance Biotherapeutics has 1,658 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.3% over the last month.
-
Twitter Followers
1658
-
Daily Change
0%
-
1 Month Change
1.3%
-
3 Month Change
5.2%
Job Postings
Iovance Biotherapeutics has an estimated 147 open job postings, which is down -0.7% over the last month.
-
Job Postings
147
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
37.4%
Reddit Mentions
Iovance Biotherapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
News Mentions
Iovance Biotherapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
LinkedIn Followers
29,128 are following Iovance Biotherapeutics on LinkedIn, up by 3.8% over the last month.
-
LinkedIn Followers
29128
-
Daily Change
0.1%
-
1 Month Change
3.8%
-
3 Month Change
12.1%
LinkedIn Employees
According to LinkedIn, Iovance Biotherapeutics has 833 employees.
-
LinkedIn Employees
833
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
5.4%
Business Outlook
According to employee reviews, the business outlook among employees at Iovance Biotherapeutics is 54 out of 100 (neutral).
-
Business Outlook
54
-
Change from Previous Month
1.8%
-
3 Month Change
0%
-
YoY Change
0%
0JDK.L Financials
0JDK.L Key Metrics
-
Total Revenue
$31.1M
-
Net Income
-$97.1M
-
Earnings per Share
-$0.34
-
Free cash flow
-$98.9M
-
EBITDA
-$93.4M
-
EBITDA Ratio
-3.00402
-
Total Assets
$964.3M
0JDK.L 2-year Revenue & Income
0JDK.L 2-year Free Cash Flow
0JDK.L Technicals
0JDK.L SMA
0JDK.L RSI
FAQ
What's the current price of Iovance Biotherapeutics (0JDK.L) Stock?
The price of an Iovance Biotherapeutics (0JDK.L) share is $3.59.
What's the market cap of Iovance Biotherapeutics?
The current market cap of Iovance Biotherapeutics is 1.2B.
Should I buy or sell 0JDK.L?
Iovance Biotherapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Iovance Biotherapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Iovance Biotherapeutics a good investment?
The current analysis of Iovance Biotherapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Iovance Biotherapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Iovance Biotherapeutics (0JDK.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Iovance Biotherapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Iovance Biotherapeutics (0JDK.L) that investors often compare it to?
Iovance Biotherapeutics (0JDK.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.
What is the forecast for Iovance Biotherapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Iovance Biotherapeutics' stock price to be around $3.62 in 2026. Starting from the current price of $3.59, this represents a 0.9% change in price, indicating a neutral outlook for the stock.
How to buy Iovance Biotherapeutics (0JDK.L) Stock?
Iovance Biotherapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Iovance Biotherapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.